You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

Infections
Letter
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

Authors

  • George E Fragoulis Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Anastasios Karamanakos Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Aikaterini Arida Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Vasiliki-Kalliopi Bournia Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Gerasimos Evangelatos Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Antonis Fanouriakis Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Kalliopi Fragiadaki Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Evrydiki Kravvariti Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Katerina Laskari Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Stylianos Panopoulos Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Nikolaos Papazoglou Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Maria Pappa Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Maria G Tektonidou Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Petros P Sfikakis Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George E Fragoulis; geofragoul{at}yahoo.gr
View Full Text

Citation

Fragoulis GE, Karamanakos A, Arida A, et al
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
RMD Open 2022;8:e002279. doi: 10.1136/rmdopen-2022-002279

Publication history

  • Accepted February 10, 2022
  • First published March 4, 2022.
Online issue publication 
March 04, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.